Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kura Oncology (KURA) Total Non-Current Liabilities: 2024-2025

Historic Total Non-Current Liabilities for Kura Oncology (KURA) over the last 2 years, with Sep 2025 value amounting to $403.9 million.

  • Kura Oncology's Total Non-Current Liabilities rose 653.54% to $403.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $403.9 million, marking a year-over-year increase of 653.54%. This contributed to the annual value of $344.7 million for FY2024, which is N/A change from last year.
  • As of Q3 2025, Kura Oncology's Total Non-Current Liabilities stood at $403.9 million, which was up 7.88% from $374.3 million recorded in Q2 2025.
  • Over the past 5 years, Kura Oncology's Total Non-Current Liabilities peaked at $403.9 million during Q3 2025, and registered a low of $47.9 million during Q2 2024.